Cranial broadband, and four wavelength, near infrared spectroscopy were used to measure changes in concentration of oxidised cytochrome oxidase in healthy volunteers during hypoxaemia. Significant changes, which reflect changes in cerebral oxygen delivery, are demonstrated.
Introduction
Cytochrome c oxidase (CCO) is the terminal electron acceptor of the mitochondrial electron transfer pathway. It catalyses over 95% of the metabolism of oxygen and drives adenosine triphosphate synthesis. Changes in the redox state of CCO therefore reflect changes in cellular energy status. The absorption spectrum of oxidised-reduced CCO has a distinct band in the near infrared region which can be measured using near infrared spectroscopy (NIRS). Assuming that the concentration of CCO remains constant over the course of an experiment then changes in the NIRS CCO signal represent changes in the redox state of CCO. Oxy-(HbO 2 ) and deoxyhaemoglobin (HHb) also have characteristic absorption spectra in the near infrared region (NIR) and NIRS can measure changes in the concentrations of these three optical chromophores using the modified Beer-Lambert law [1] The aim of this study was to measure changes in the concentration of cerebral oxidised cytochrome oxidase (Δ[ox-redCCO]) using both broadband and four wavelength near infrared spectroscopy systems during an isocapnoeic hypoxaemic challenge in healthy human adults.
Experimental Methods
14 healthy volunteers were studied following local ethics committee approval and written consent. 12 complete datasets were produced (9 male, 3 female, median age 30.5 years, range 26-36). NIRS optodes from a continuous wave, four wavelength spectrometer with a sampling rate of 6 Hz (NIRO 300, Hamamatsu Photonics KK) were placed on the forehead with channel 1 on the right and channel 2 on the left, and a detector emitter separation of 5 cm. The optodes from a broadband spectrometer (BBS) were placed high on the right side of the forehead with a detector emitter separation of 3.5 cm. Light from a tungsten halogen source was long pass filtered and transmitted to the head via a glass optic fibre bundle. Detected light was focused onto the slits of a 300 g/mm spectrograph grating (270M, Instruments SA), allowing collection of NIR spectra between 650 and 980 nm to a cooled charge coupled device detector (Wright Instruments, Enfield, UK) at a spectral resolution of ~5 nm. Data were collected at 1Hz. Non-invasive arterial oxygen saturation (SaO 2 ) and blood pressure were collected from the left ear and left index finger respectively. Blood flow velocity in the right middle cerebral artery (vMCA) was measured continuously using transcranial Doppler ultrasonography and an anaesthetic machine delivered gas to the subject via mouthpiece.
The study protocol consisted of initial period of five minutes baseline monitoring at normoxia and normocapnoea. The inspired oxygen concentration (FiO 2 ) was reduced, by the addition of nitrogen, to induce a fall in SaO 2 to 80%. The FiO 2 was then returned to baseline for five minutes. This cycle was repeated three times and the study finished with a further period of baseline recording. End tidal partial pressure of carbon dioxide (EtCO 2 ) was continuously fed back to subjects throughout the study and they were instructed to maintain normocapnoea.
Data Analysis
Absolute changes in chromophore concentrations were calculated from changes in light attenuation and normalised to the baseline optical pathlength, calculated for the NIRO 300 data assuming a differential pathlength factor of 6.26 [2] , and measured for the BBS data using second differential analysis of the 740 nm water feature [3] . The start and end of each hypoxia was identified by manually finding the corresponding drop from, and return to, baseline of the FiO 2 . Mean changes for the three hypoxias from baseline to end of hypoxia, and baseline to end of recovery for each subject were compared using non-parametric ANOVA with post hoc pairwise comparisons.
The group data were described by dividing the time course of the hypoxia and recovery periods into 16 epochs and calculating median change from baseline for each period. Changes in vMCA reflect changes in cerebral blood flow [4] and so, assuming constant arterial haemoglobin concentration over the course of the study, change in estimated oxygen delivery (ΔeDO 2 ) is calculated as percentage change from baseline of SaO 2 *vMCA. The group data are presented here as median (interquartile range). At the nadir of hypoxaemia, the reduction in SaO 2 was 15.9(13.9-17.3) % and this corresponded with a reduction in eDO 2 of 6 (3-10) % and an increase in heart rate of 14.7(10.6-15.5) beats per minute. The reduction in [ox-redCCO] was 0.12(0.07-0.17) μM for NIRO 300 channel 1, 0.05(0.04-0.10) μM for NIRO 300 channel 2 and 0.27(0.06-0.28) μM for the BBS. At this point, the changes in SaO 2 , eDO 2 , heart rate and the three measured Δ[ox-redCCO] values were statistically significant (p<0.05 for change from baseline). There were no significant changes in EtCO 2 or mean blood pressure during the study.
Results

Discussion
This paper describes a significant reduction in [ox-redCCO] measured using two different NIRS systems during severe isocapnoeic hypoxaemia in healthy adult humans. The magnitude of the measured concentration change differed between both the two channels of the NIRO 300 (channel 1 -0.12 μM, channel 2 -0.05 μM), and the BBS (-0.27 μM). This may be related to the exact positioning of the optodes on the head, the different inter-optode spacings used or the different pathlength corrections. Pathlength will vary depending on the optical properties of the interrogated tissue and the BBS system's ability to directly calculate pathlength may therefore be beneficial. NIRS measured changes in [ox-redCCO] have been described in animals [5] and have been validated as a marker of cellular energy failure against magnetic resonance spectroscopy measured reduction in phosphocreatine levels [6] ,but using much more severe hypoxaemia than would be ethical in humans. Our previous work has described significant [oxredCCO] concentration changes of 0.1-0.5 μM associated with obstructive sleep apnoea in adults, where severe desaturations inducing drops in SaO 2 down to 50-80% were observed [7] , but to our knowledge this is the first description of the magnitude of [ox-redCCO] reduction during a reproducible and ethical hypoxaemia in healthy adults. Changes in the partial pressure of carbon dioxide have been shown to affect [ox-redCCO] [8] and so to investigate the independent effect of hypoxaemia it is essential to maintain a constant EtCO 2 . This was achieved in our study by continuously feeding back the EtCO 2 to the subjects and their voluntary control of minute ventilation. During the hypoxaemic phase eDO 2 decreases, however cerebral vasodilatation also occurs and on returning the It has been suggested that changes in the optical properties of the brain caused by large changes in chromophore concentrations can lead to artefacts in the observed Δ[ox-redCCO] [9] . The BBS data in particular suggest that, in this subject group, the CCO signal is able to measure an independent variable which reflects changes in cerebral DO 2 .
We describe an ethical, repeatable adult protocol which appears to produce changes in [ox-redCCO], and provides an ideal model for further investigation of the CCO signal. This signal has potential as a clinical tool for assessing changes in cerebral cellular redox state after brain injury.
References
